Another year, another B!
April 8, 2024 | Carbon Disclosure, Climate change, Pharma, Sustainability, healthcare comms
Louise Jones, Cuttsy+Cuttsy’s Sustainability Officer reflects on their latest year of carbon reporting through CDP and on achieving another B rating.
Yes, we’ve been awarded another B rating from Carbon Disclosure Project (CDP)! This is the second-highest rating available from CDP (which monitors environmental impact and risk management) and shows that we have been able to maintain our commitment to sustainability for the past 12 months, resulting in us being rewarded with another top rating!
The past year has been particularly momentous for us; we achieved net zero in both Scopes 1 and 2 (you’ll find more about the scope definitions here), which means we have just Scope 3 to conquer. Scope 3, which encompasses emissions resulting from the entire value chain, represents our last barrier to becoming a net zero company. And while achieving true net zero may be a challenge given the current technological landscape, our commitment is unwavering. We’re absolutely determined to get as close to zero as humanly possible!
Disclosing our progress through CDP is a crucial part of our bigger sustainability strategy, and with two years of experience under our belts, we’re embracing new changes in CDP’s submission structure as we head into 2024.
We’ve definitely encountered some roadblocks along the way. The main one being the complexity and time needed to accurately carbon report.
But there is light – after attending the CDP conference last year, we were given the welcome news of the questionnaire’s re-design, which hugely simplifies the reporting process. Firstly, by improving user-friendliness, and secondly (which is likely to be a very significant and far-reaching change), the merging of the climate, forestry, and water questionnaires. This promises to not only streamline the reporting process but for the likes of yours truly who is tasked with annual reporting, brings huge relief!
These changes are also likely to be big drivers in getting get more companies to participate in the scheme and disclose the details of their sustainability efforts. Because an accurate measurement of everyone’s impact is, after all, the only way to achieve true and effective global change. And CDP are clearly showing their commitment to this critical goal.
As we navigate through these improvements and challenges, Cuttsy+Cuttsy remains steadfast in its commitment to sustainability. And we look forward to making even greater strides in the coming years. Here’s to another year of progress and collective efforts towards a sustainable future.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
A month of insights: Key takeaways from May’s conferences
Explore key insights from some of May’s top healthcare conferences, covering patient engagement, health equity, co-creation, and tech innovation shaping clinical trials.
Cuttsy+Cuttsy and ISPEP highlight key patient insights in new clinical trials report
Explore how Cuttsy+Cuttsy and ISPEP are spotlighting patient engagement in clinical trials through a new global report.
Motivations that matter: Understanding clinical trial participation to create better research
Understanding why people join clinical trials is essential to improving recruitment and designing better research. Explores the diverse motivations driving participation — from altruism and hope for better health to...
Cuttsy+Cuttsy welcomes new team members and celebrates a familiar face returning
Cuttsy+Cuttsy proudly announces the expansion of its team with the addition of three new hires—Michelle, Jay, and Emily—and the welcome return of former team member Sally as Account Director.
AI and away we go: key insights from Reuters Pharma 2025
AI is revolutionising the pharmaceutical industry, as highlighted at Reuters Pharma 2025, with transformative applications across marketing, drug discovery, and patient engagement, despite challenges in adoption, regulation, and data trust.
Exciting updates from our content and strategy team
Cuttsy+Cuttsy celebrates new beginnings with the appointment of Oli Bailey as Strategy Director and recognises team excellence through several well-deserved promotions.
How is generative AI transforming clinical trials?
Discover how generative AI is revolutionising clinical trials, from enhancing patient recruitment to improving data analysis.
Content for all – how to connect with neurodiverse audiences
Discover essential strategies for crafting inclusive and accessible written content tailored for neurodivergent readers.
Cuttsy+Cuttsy launches ccura: AI powered, always human
Cuttsy+Cuttsy introduces ccura, an AI-powered healthcare communications platform that blends technology with human expertise to enhance collaboration, streamline workflows, and deliver patient-focused, high-quality solutions with security and compliance at its...
Two Sides of the Same Coin: Patient Engagement vs Patient Involvement
Unpack the difference between patient engagement and patient involvement.